2012
DOI: 10.1002/path.4115
|View full text |Cite
|
Sign up to set email alerts
|

Fibroblast autophagy in fibrotic disorders

Abstract: Fibrotic disorders are multistage progressive processes that often arise from different causes and are commonly associated with chronic inflammation. Excessive deposition of extracellular matrix is the hallmark of many fibrotic diseases. This may be due to an excess of fibroblast recruitment and activation, as well as to their differentiation in myofibroblasts. These events may be triggered by cytokines, chemokines and growth factors released by lymphocytes or macrophages. The excessive production of extracell… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
45
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 68 publications
(49 citation statements)
references
References 173 publications
(239 reference statements)
4
45
0
Order By: Relevance
“…Recent studies implicate dysregulated autophagy in disorders characterized by fibrosis in various tissues, including cardiac fibrosis, liver fibrosis, and idiopathic pulmonary fibrosis. 43 We have recently reported a critical role of autophagy in negatively regulating matrix production in glomerular mesangial cells by promoting degradation of intracellular Col-I induced by TGFb1. 28 Moreover, inhibition of autophagy by a selective chemical inhibitor, 3-methyladenine, has been shown to enhance interstitial fibrosis in the obstructed kidneys after UUO in rats.…”
Section: Discussionmentioning
confidence: 99%
“…Recent studies implicate dysregulated autophagy in disorders characterized by fibrosis in various tissues, including cardiac fibrosis, liver fibrosis, and idiopathic pulmonary fibrosis. 43 We have recently reported a critical role of autophagy in negatively regulating matrix production in glomerular mesangial cells by promoting degradation of intracellular Col-I induced by TGFb1. 28 Moreover, inhibition of autophagy by a selective chemical inhibitor, 3-methyladenine, has been shown to enhance interstitial fibrosis in the obstructed kidneys after UUO in rats.…”
Section: Discussionmentioning
confidence: 99%
“…Intriguingly, depending on the cell or tissue type and pathological settings, autophagy can be profibrotic or antifibrotic in these organs. [22][23][24][25] For example, autophagy induced in hepatic stellate cells can break down lipids to fuel the activation of these cells to promote liver fibrosis. 26,27 In contrast, autophagy in hepatic macrophages and hepatocytes inhibits inflammation and apoptosis, resulting in the prevention of liver fibrosis.…”
Section: Introductionmentioning
confidence: 99%
“…23 Recent studies have highlighted a correlation between dysregulated autophagy and the development of fibrosis. 24 Both up-and downregulation of autophagy have been associated with fibrosis in various organs, highlighting the potentially diverse functional role that autophagy may play in the various phases of response to stress and tissue repair. 24 In models of liver fibrosis, reduced autophagy was shown to prevent differentiation of hepatic stellate cells into myofibroblast-like cells, therefore leading to reduced fibrogenesis.…”
Section: Introductionmentioning
confidence: 99%
“…24 Both up-and downregulation of autophagy have been associated with fibrosis in various organs, highlighting the potentially diverse functional role that autophagy may play in the various phases of response to stress and tissue repair. 24 In models of liver fibrosis, reduced autophagy was shown to prevent differentiation of hepatic stellate cells into myofibroblast-like cells, therefore leading to reduced fibrogenesis. 25,26 Fibrogenic cells of kidney and lung origin have also been shown to rely on autophagy to maintain an activated and fibrogenic phenotype.…”
Section: Introductionmentioning
confidence: 99%